We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Fishing trip

13 Jul 2020 By Aimee Donnellan

Davidson Kempner wants Thermo Fisher Scientific to up its $11.5 bln bid for peer Qiagen. The German group’s business is improving as governments use its kits to fight the coronavirus. The recent rally in diagnostic stocks, and potential counterbids, mean there is little to lose.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)